BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4271060)

  • 1. The epidermal chalone mechanism.
    Bullough WS
    Natl Cancer Inst Monogr; 1973 Jul; 38():99-107. PubMed ID: 4271060
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental approach to the epidermal chalone.
    Laurence EB
    Natl Cancer Inst Monogr; 1973 Jul; 38():37-45. PubMed ID: 4271051
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidermal chalone: cell cycle specificity of two epidermal growth inhibitors.
    Elgio K
    Natl Cancer Inst Monogr; 1973 Jul; 38():71-6. PubMed ID: 4271055
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on "Epidermal chalone: cell cycle specificity of two epidermal growth inhibitors" by K. Elgjo.
    Fell HB
    Natl Cancer Inst Monogr; 1973 Jul; 38():77-8. PubMed ID: 4271056
    [No Abstract]   [Full Text] [Related]  

  • 5. The chalones: a review.
    Bullough WS
    Natl Cancer Inst Monogr; 1973 Jul; 38():5-16. PubMed ID: 4271052
    [No Abstract]   [Full Text] [Related]  

  • 6. The epidermal chalone and keratinizing epithelia.
    Laurence EB
    Natl Cancer Inst Monogr; 1973 Jul; 38():61-8. PubMed ID: 4271053
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver chalone: a review.
    Stack-Dunne MP
    Natl Cancer Inst Monogr; 1973 Jul; 38():185-8. PubMed ID: 4271042
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidermal chalone--an agent controlling the growth of the epidermis].
    Moskalewski S
    Przegl Dermatol; 1971; 58(3):349-53. PubMed ID: 4257402
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of epidermal chalone and epidermal growth factor on a transplantable epidermal carcinoma (Hewitt) of the mouse in vivo.
    Bertsch S; Marks F
    Cancer Res; 1979 Jan; 39(1):239-43. PubMed ID: 153788
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on "The epidermal chalone and keratinizing epithelia" by E. B. Laurence.
    Hennings H
    Natl Cancer Inst Monogr; 1973 Jul; 38():69-70. PubMed ID: 4271054
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermal growth control mechanisms, hyperplasia, and tumor promotion in the skin.
    Marks F
    Cancer Res; 1976 Jul; 36(7 PT 2):2636-43. PubMed ID: 179707
    [No Abstract]   [Full Text] [Related]  

  • 12. [Change in the activity of epidermal chalones during skin reaction to the effect of a carcinogen and epilation].
    Ketlinskiĭ SA; Okulov VB
    Biull Eksp Biol Med; 1978 Mar; 85(3):354-6. PubMed ID: 149573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cyclic AMP in the control of epidermal cell growth and differentiation.
    Voorhees JJ; Duell EA; Bass LJ; Harrell ER
    Natl Cancer Inst Monogr; 1973 Jul; 38():47-59. PubMed ID: 4356798
    [No Abstract]   [Full Text] [Related]  

  • 14. Chalone regulation of cell proliferation.
    Thornley AL
    S Afr J Med Sci; 1976; 41(3):239-54. PubMed ID: 136048
    [No Abstract]   [Full Text] [Related]  

  • 15. Description of growth phenomena and the formulation of growth control models.
    Simnett JD; Fisher JM
    Natl Cancer Inst Monogr; 1973 Jul; 38():29-36. PubMed ID: 4271050
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of leukocytes.
    Lajtha LG
    Natl Cancer Inst Monogr; 1973 Jul; 38():111-5. PubMed ID: 4271033
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tissue-specific regulation of proliferative processes in the tissues normally and in pathology: on the problem of chalones].
    Ketlinskiĭ SA
    Arkh Patol; 1978; 40(3):3-13. PubMed ID: 148259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study.
    Athar M; An KP; Morel KD; Kim AL; Aszterbaum M; Longley J; Epstein EH; Bickers DR
    Biochem Biophys Res Commun; 2001 Feb; 280(4):1042-7. PubMed ID: 11162632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.